Tuesday, February 01, 2022 6:59:04 AM
We have Biden's Project Moon Shot that set out to cure cancer
https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative
We have the Gates Foundation investing in cancer vaccines
https://www.businessinsider.com/bill-gates-cancer-therapies-could-control-all-infectious-disease-2018-1
The NIH receives $41.7 billion each year
https://www.nih.gov/about-nih/what-we-do/budget
If all these powerful business and political forces would stop playing politics and being in for the money and to remain powerful they would recognize that NWBO has an effective treatment . . . really a cure for many with GBM that really has no effective treatment currently and is likely an effective treatment for most other solid tumors cancers.
NWBO needs to get the journal article published and top line released so that there is not longer any doubt in the effectiveness of DCVAX.
If the world is serious about curing cancer then there should be large grants and other funding provided to ramp up volume manufacturing for DCVAX to not just 100's or 1000's of treatments per year but to 100's of 1000's, to reduce the cost of the treatment and to accelerate DCVAX-Direct.
You really want a Project Moon Shot that works Joe, that cures cancer . . . well here it is.
That's the light at the end of the tunnel.
. . . but alas it will never happen. That is not the greedy political world we live in.
Men who are occupied in the restoration of health to other men, by the joint exertion of skill and humanity, are above all the great of the earth. They even partake of divinity, since to preserve and renew is almost as noble as to create.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
